Newsroom

Sorted by: Latest
-

Omega Announces Fourth Quarter Earnings Release Date and Conference Call

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2025, on Wednesday, February 4, 2026, after market close. In conjunction with its release, Omega will conduct a conference call on Thursday, February 5, 2026, at 10 a.m. Eastern Time to review its 2025 fourth quarter results and current developments. Investors and other interested parties may access the conference...
-

Western Alliance Bancorporation Announces Fourth Quarter and Full Year 2025 Earnings Release Date, Conference Call and Webcast

PHOENIX--(BUSINESS WIRE)--Western Alliance Bancorporation Announces Fourth Quarter and Full Year 2025 Earnings Release Date, Conference Call and Webcast...
-

Siemens e NVIDIA ampliam parceria para construir o sistema operacional de IA industrial

LAS VEGAS--(BUSINESS WIRE)--CES 2026 - A Siemens e a NVIDIA anunciaram hoje uma expansão significativa de sua parceria estratégica para levar a inteligência artificial ao mundo real. Juntas, as empresas pretendem desenvolver soluções de IA industriais e físicas que levarão a inovação impulsionada por IA a todos os setores e fluxos de trabalho industriais, além de acelerar as operações de ambas as empresas. Para apoiar o desenvolvimento, a NVIDIA fornecerá infraestrutura de IA, bibliotecas de si...
-

Mark Farrah Associates Assesses Year-End Private-Sector Health Insurance Business

MCMURRAY, Pa.--(BUSINESS WIRE)--MFA presents an updated overview of high-level health benefit insights gleaned from MFA’s 5500 Employer Health Plus....
-

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases, today announced the closing of its previously announced registered direct offering, with a single healthcare-focused institutional investor, for the issuance and sale of 4,063,290 shares of the Company’s common stock and 1,000,000 pre-funded warrants....
-

SonicEdge annonce un partenariat d'intégration de semiconducteurs au CES 2026 alors que la technologie des ultrasons modulés gagne en adoption par l'industrie

BINYAMINA-GIV'AT ADA, Israël--(BUSINESS WIRE)--SonicEdge, the modulated ultrasound pioneer, announces strategic partnership with leading chip manufacturer and showcases latest offerings at CES 26....
-

Resumen: SonicEdge anuncia una alianza para la integración de semiconductores en el CES 2026, en el marco de la creciente aceptación de la tecnología de ultrasonidos modulados en la industria

BINYAMINA-GIV'AT ADA, Israel--(BUSINESS WIRE)--SonicEdge, pionera en innovación microacústica, ha anunciado hoy durante el CES 2026 que ha establecido una nueva asociación estratégica con un fabricante líder mundial de semiconductores para integrar su IP de ultrasonidos modulados directamente en los chipsets de audio de la próxima generación, que controlarán de forma nativa los altavoces de ultrasonido modulado de SonicEdge. Estiman que otras importantes empresas de chips seguirán su ejemplo, d...
-

SonicEdge gibt auf der CES 2026 eine Partnerschaft zur Integration von Halbleitern bekannt, da die modulierte Ultraschalltechnologie zunehmend in der Industrie Anwendung findet

BINYAMINA-GIV'AT ADA, Israel--(BUSINESS WIRE)--SonicEdge, the modulated ultrasound pioneer, announces strategic partnership with leading chip manufacturer and showcases latest offerings at CES 26....
-

UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--United BioSource LLC (UBC) today announced it has acquired Evidinno Outcomes Research Inc. (Evidinno), a healthcare research consulting firm headquartered in Vancouver, Canada specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical & economic analysis. UBC partners with biopharma to modernize evidence development and patient access pathways, ensuring therapies are safe, effective, and available to those who...
-

Sprosty Bag Announces Strategic Partnership with KCN Companies

SMITHVILLE, Ohio--(BUSINESS WIRE)--Sprosty Bag Announces Strategic Partnership with KCN Companies...